Very High-Risk ASCVD and Eligibility for Nonstatin Therapies Based on the 2018 AHA/ACC Cholesterol Guidelines

Salim S. Virani, Julia M. Akeroyd, Sidney C. Smith, Mouaz Al-Mallah, Thomas M. Maddox, Pamela B. Morris, Laura A. Petersen, Christie M. Ballantyne, Scott M. Grundy, Neil J. Stone

Research output: Contribution to journalLetterpeer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'Very High-Risk ASCVD and Eligibility for Nonstatin Therapies Based on the 2018 AHA/ACC Cholesterol Guidelines'. Together they form a unique fingerprint.